SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 254 filers reported holding SAGE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $229,000 | -24.9% | 4,039 | -0.8% | 0.00% | 0.0% |
| Q1 2021 | $305,000 | -5.6% | 4,071 | +9.2% | 0.00% | 0.0% |
| Q4 2020 | $323,000 | +41.7% | 3,729 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $228,000 | -32.5% | 3,729 | -20.3% | 0.00% | -50.0% |
| Q4 2019 | $338,000 | -49.9% | 4,676 | -2.7% | 0.00% | -50.0% |
| Q3 2019 | $674,000 | -30.2% | 4,807 | -8.9% | 0.00% | -20.0% |
| Q2 2019 | $966,000 | +12.2% | 5,274 | -2.6% | 0.01% | +25.0% |
| Q1 2019 | $861,000 | +274.3% | 5,413 | +125.2% | 0.00% | +300.0% |
| Q4 2018 | $230,000 | -38.5% | 2,404 | -9.2% | 0.00% | -50.0% |
| Q3 2018 | $374,000 | -63.5% | 2,648 | -59.6% | 0.00% | -66.7% |
| Q2 2018 | $1,025,000 | +128.8% | 6,551 | +135.6% | 0.01% | +100.0% |
| Q1 2018 | $448,000 | -7.6% | 2,780 | -5.5% | 0.00% | 0.0% |
| Q4 2017 | $485,000 | – | 2,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
| Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
| EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
| New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
| AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
| APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
| OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
| Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |